120 related articles for article (PubMed ID: 38048842)
21. Association analysis between polymorphisms in the myo-inositol monophosphatase 2 (IMPA2) gene and bipolar disorder.
Bloch PJ; Weller AE; Doyle GA; Ferraro TN; Berrettini WH; Hodge R; Lohoff FW
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Dec; 34(8):1515-9. PubMed ID: 20800640
[TBL] [Abstract][Full Text] [Related]
22. Estrogen receptor-alpha promoter methylation in sporadic basal-like breast cancer of Chinese women.
Jing MX; Mao XY; Li C; Wei J; Liu C; Jin F
Tumour Biol; 2011 Aug; 32(4):713-9. PubMed ID: 21625942
[TBL] [Abstract][Full Text] [Related]
23. Examination of IMPA1 and IMPA2 genes in manic-depressive patients: association between IMPA2 promoter polymorphisms and bipolar disorder.
Sjøholt G; Ebstein RP; Lie RT; Berle JØ; Mallet J; Deleuze JF; Levinson DF; Laurent C; Mujahed M; Bannoura I; Murad I; Molven A; Steen VM
Mol Psychiatry; 2004 Jun; 9(6):621-9. PubMed ID: 14699425
[TBL] [Abstract][Full Text] [Related]
24. Integrated molecular pathway analysis informs a synergistic combination therapy targeting PTEN/PI3K and EGFR pathways for basal-like breast cancer.
She QB; Gruvberger-Saal SK; Maurer M; Chen Y; Jumppanen M; Su T; Dendy M; Lau YK; Memeo L; Horlings HM; van de Vijver MJ; Isola J; Hibshoosh H; Rosen N; Parsons R; Saal LH
BMC Cancer; 2016 Aug; 16():587. PubMed ID: 27484095
[TBL] [Abstract][Full Text] [Related]
25. Protein expression and methylation of DNA repair genes hMLH1, hMSH2, MGMT and BRCA1 and their correlation with clinicopathological parameters and prognosis in basal-like breast cancer.
Alkam Y; Mitomi H; Nakai K; Himuro T; Saito T; Takahashi M; Arakawa A; Yao T; Saito M
Histopathology; 2013 Nov; 63(5):713-25. PubMed ID: 24004112
[TBL] [Abstract][Full Text] [Related]
26. Dysregulation of the miR-25-IMPA2 axis promotes metastatic progression in clear cell renal cell carcinoma.
Lin YF; Chou JL; Chang JS; Chiu IJ; Chiu HW; Lin YF
EBioMedicine; 2019 Jul; 45():220-230. PubMed ID: 31202813
[TBL] [Abstract][Full Text] [Related]
27. Investigation of Transcript Variant 6 of
Zhang X; O'Brien D; Zhang X
Oxid Med Cell Longev; 2022; 2022():7078787. PubMed ID: 36071863
[TBL] [Abstract][Full Text] [Related]
28. A feedforward circuit between KLF5 and lncRNA KPRT4 contributes to basal-like breast cancer.
Du G; Sun J; Li Z; Zhang Q; Liu W; Yang C; Zhao P; Wang X; Yin Q; Luo Y; Song J; Wen Y; Wang H; Chen CH; Hu G; Zhou Z; Mao X; Liu W; Liu Z; Jiang D; Chen C
Cancer Lett; 2022 May; 534():215618. PubMed ID: 35259457
[TBL] [Abstract][Full Text] [Related]
29. Dysregulated expression of Slug, vimentin, and E-cadherin correlates with poor clinical outcome in patients with basal-like breast cancer.
Liu T; Zhang X; Shang M; Zhang Y; Xia B; Niu M; Liu Y; Pang D
J Surg Oncol; 2013 Feb; 107(2):188-94. PubMed ID: 22886823
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of UGT8 suppresses basal-like breast cancer progression by attenuating sulfatide-αVβ5 axis.
Cao Q; Chen X; Wu X; Liao R; Huang P; Tan Y; Wang L; Ren G; Huang J; Dong C
J Exp Med; 2018 Jun; 215(6):1679-1692. PubMed ID: 29728441
[TBL] [Abstract][Full Text] [Related]
31. CIP2A Interacts with TopBP1 and Drives Basal-Like Breast Cancer Tumorigenesis.
Laine A; Nagelli SG; Farrington C; Butt U; Cvrljevic AN; Vainonen JP; Feringa FM; Grönroos TJ; Gautam P; Khan S; Sihto H; Qiao X; Pavic K; Connolly DC; Kronqvist P; Elo LL; Maurer J; Wennerberg K; Medema RH; Joensuu H; Peuhu E; de Visser K; Narla G; Westermarck J
Cancer Res; 2021 Aug; 81(16):4319-4331. PubMed ID: 34145035
[TBL] [Abstract][Full Text] [Related]
32. Rho GTPase Transcriptome Analysis Reveals Oncogenic Roles for Rho GTPase-Activating Proteins in Basal-like Breast Cancers.
Lawson CD; Fan C; Mitin N; Baker NM; George SD; Graham DM; Perou CM; Burridge K; Der CJ; Rossman KL
Cancer Res; 2016 Jul; 76(13):3826-37. PubMed ID: 27216196
[TBL] [Abstract][Full Text] [Related]
33. AGR2 and AGR3 play an important role in the clinical characterization and prognosis of basal like breast cancer.
de Moraes CL; Cruz E Melo N; Valoyes MAV; Naves do Amaral W
Clin Breast Cancer; 2022 Feb; 22(2):e242-e252. PubMed ID: 34462207
[TBL] [Abstract][Full Text] [Related]
34. Basal-like breast cancer with low TGFβ and high TNFα pathway activity is rich in activated memory CD4 T cells and has a good prognosis.
Liu D; Vadgama J; Wu Y
Int J Biol Sci; 2021; 17(3):670-682. PubMed ID: 33767579
[TBL] [Abstract][Full Text] [Related]
35. Cancer Cell Intrinsic and Immunologic Phenotypes Determine Clinical Outcomes in Basal-like Breast Cancer.
Li CI; Zhang Y; Cieślik M; Wu YM; Xiao L; Cobain E; Tang MC; Cao X; Porter P; Guenthoer J; Robinson DR; Chinnaiyan AM
Clin Cancer Res; 2021 Jun; 27(11):3079-3093. PubMed ID: 33753452
[TBL] [Abstract][Full Text] [Related]
36. The suppression of DUSP5 expression correlates with paclitaxel resistance and poor prognosis in basal-like breast cancer.
Liu T; Sun H; Liu S; Yang Z; Li L; Yao N; Cheng S; Dong X; Liang X; Chen C; Wang Y; Zhao X
Int J Med Sci; 2018; 15(7):738-747. PubMed ID: 29910679
[TBL] [Abstract][Full Text] [Related]
37. Triple-negative breast cancer: distinguishing between basal and nonbasal subtypes.
Rakha EA; Elsheikh SE; Aleskandarany MA; Habashi HO; Green AR; Powe DG; El-Sayed ME; Benhasouna A; Brunet JS; Akslen LA; Evans AJ; Blamey R; Reis-Filho JS; Foulkes WD; Ellis IO
Clin Cancer Res; 2009 Apr; 15(7):2302-10. PubMed ID: 19318481
[TBL] [Abstract][Full Text] [Related]
38. HDAC8 suppresses the epithelial phenotype and promotes EMT in chemotherapy-treated basal-like breast cancer.
Pantelaiou-Prokaki G; Mieczkowska I; Schmidt GE; Fritzsche S; Prokakis E; Gallwas J; Wegwitz F
Clin Epigenetics; 2022 Jan; 14(1):7. PubMed ID: 35016723
[TBL] [Abstract][Full Text] [Related]
39. p16INK4a expression in basal-like breast carcinoma.
Bohn OL; Fuertes-Camilo M; Navarro L; Saldivar J; Sanchez-Sosa S
Int J Clin Exp Pathol; 2010 Jun; 3(6):600-7. PubMed ID: 20661408
[TBL] [Abstract][Full Text] [Related]
40. PACT promotes the metastasis of basal-like breast cancer through Rac1 SUMOylation and activation.
Wei L; Wang W; Yao J; Cui Z; Xu Z; Ding H; Wu X; Wang D; Luo J; Ke ZJ
Oncogene; 2022 Sep; 41(37):4282-4294. PubMed ID: 35974143
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
